Back
 JBM  Vol.6 No.8 , August 2018
Metabolic Syndrome, and Cardiovascular Risk among Mentally Ill Patients
Abstract: Patients with serious mental illness have an increased prevalence of the metabolic syndrome in comparison to the general population. Metabolic syndrome is a constellation of cardiovascular risk factors including diabetes, hypertension, obesity and dyslipidemia. It is potentially reversible and may explain the higher incidence of cardiovascular disease in patients with serious mental illness. The aim of the study is to see the prevalence of metabolic syndrome among mentally ill patients and what might be the underlying the cause behind the scene A descriptive, retrospective study was conducted at mental health clinic, Batticaloa, Teaching Hospital (BTH), Sri Lanka. The data were collected over a period of two months from 15th of October to 15th of December 2017. Data were harvested from the medical records. Total 55 mentally ill patient’s medical records were analyzed for this study. Out of 55, females were 30 (54.5%) and males were 25 (45.5%). Furthermore, 30 (54.5%) patients had an evidence of metabolic syndrome. The association of metabolic syndrome among male and female was not statistically significant (P > 0.05). In this study, metabolic syndrome is more prevalent among, patient with trifluoperazine (70%) drug group, risperidone (66.6%) and olanzapine (53.12%).
Cite this paper: Umakanth, M. and Gadambanathan, T. (2018) Metabolic Syndrome, and Cardiovascular Risk among Mentally Ill Patients. Journal of Biosciences and Medicines, 6, 72-79. doi: 10.4236/jbm.2018.68006.
References

[1]   Papanastasiou, E. (2013) The Prevalence and Mechanisms of Metabolic Syndrome in Schizophrenia: A Review. Therapeutic Advances in Psychopharmacology, 3, 33-51.

[2]   Ford, E.S., Giles, W.H. and Dietz, W.H. (2002) Prevalence of the Metabolic Syndrome among US Adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA, 287, 356-359.
https://doi.org/10.1001/jama.287.3.356

[3]   Toalson, P., Ahmed, S., Hardy, T. and Kabinoff, G. (2004) The Metabolic Syndrome in Patients with Severe Mental Illnesses. The Primary Care Companion to the Journal of Clinical Psychiatry, 6, 152-158.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=514841&tool=pmcentrez&rendertype=abstract
https://doi.org/10.4088/PCC.v06n0402


[4]   Umakanth, M. and Gadambanathan, T. (2018) Over Weight and Obesity among Mentally Ill Patients. Saudi Journal of Medical and Pharmaceutical Sciences, 4, 124-126.

[5]   Mondelli, V., Anacker, C., Vernon, A.C., Cattaneo, A., Natesan, S., Modo, M., et al. (2013) Haloperidol and Olanzapine Mediate Metabolic Abnormalities through Different Molecular Pathways. Translational Psychiatry, 3, e208.
https://doi.org/10.1038/tp.2012.138

[6]   Kato, M., Sotelo, J., de Guia, C., et al. (2003) Prevalence of the Metabolic Syndrome in Hispanic Patients with Mood Disorder: A Pilot Study. 156th Annual Meeting of the American Psychiatric Association, San Francisco, 17-22 May 2003, 17-22.

[7]   Lee, J., Nurjono, M., Wong, A. and Salim, A. (2012) Prevalence of Metabolic Syndrome among Patients with Schizophrenia in Singapore. Annals Academy of Medicine, Singapore, 41, 457-462.

[8]   Misiak, B., Frydecka, D., Laczmanski, L., Slezak, R. and Kiejna, A. (2014) Effects of Second-Generation Antipsychotics on Selected Markers of One-Carbon Metabolism and Metabolic Syndrome Components in First-Episode Schizophrenia Patients. European Journal of Clinical Pharmacology, 70, 1433-1441.
https://doi.org/10.1007/s00228-014-1762-2

[9]   Newcomer, J. (2007) Antipsychotic Medications: Metabolic and Cardiovascular Risk. The Journal of Clinical Psychiatry, 4, 8-13.

[10]   Mitchell, A.J., Vancampfort, D., De Herdt, A., Yu, W.P. and De Hert, M. (2013) Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A comparative Meta-Analysis of First Episode, Untreated and Treated Patients. Schizophrenia Bulletin, 39, 295-305.
https://doi.org/10.1093/schbul/sbs082

[11]   Osborn, D.P., Wright, C.A., Levy, G., King, M.B., Deo, R. and Nazareth, I. (2008) Relative Risk of Diabetes, Dyslipidaemia, Hypertension and the Metabolic Syndrome in People with Severe Mental Illnesses: Systematic Review and Metaanalysis. BMC Psychiatry, 8, 84.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_
uids=18817565%5Cnhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570660/pdf/
1471-244X-8-84.pdf


[12]   Scott, E.M., Hermens, D.F., White, D., Naismith, S.L., GeHue, J., Whitwell, B.G., et al. (2015) Body Mass, Cardiovascular Risk and Metabolic Characteristics of Young Persons Presenting for Mental Healthcare in Sydney, Australia. BMJ Open, 5, e007066.

 
 
Top